Searched for
WOCKHARDT GROUP
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt, Jemincare partner for novel respiratory antibiotic NafithromycinOn the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-M...
- Wockhardt to sell 62 products, Baddi unit to Dr Reddy’s for Rs 1,850 croreIn a regulatory filing on Wednesday, Wockharrdt said Dr Reddy’s Labs will acquire 62 products and its unit in Baddi, Himachal Pradesh in a ...
- Wockhardt Hospitals aims at business from tier-II townsAs the group clambers out of a debt trap, Habib Khorakiwala’s daughter Zahabiya plans strategy to get hospital biz back on track.
- Danone completes acquisition of Wockhardt Group’s nutrition businessFoods company, Danone today announced the completion of its acquisition of Wockhardt Group’s nutrition business.
- Wockhardt down more than 7 per cent as court admits debtors' petitionShares of Wockhardt fell more than 7 per cent in early trades on newspaper reports that the Bombay High Court on Friday admitted a winding-...
- QVT considers filing winding up petitions against WockhardtUS-based investor fund QVT Advisers is understood to be considering filing winding up petitions in the US, the UK and other countries again...
- Fortis to buy key Wockhardt hospitals for Rs 1k crFortis Healthcare is all set to buy some of Wockhardt’s key hospitals in a transaction that will see it edge closer to industry leader Apol...
- Wockhardt expects stake sale in hospital biz by May-endDebt-ridden Wockhardt Group expects to seal a deal to sell a minority stake in its healthcare chain, Wockhardt Hospitals, by May-end.
- Wockhardt Towers up for saleThe Khorakiwala family, the promoters of Wockhardt, one of India’s leading pharma firms, has put its headquarters, Wockhardt Towers, on the...
- Wockhardt Group to invest Rs 1,000 cr in next three yearsWockhardt group will invest Rs 1,000 crore in the next three years for expanding its healthcare infrastructure.
- Wockhardt to double number of hospitals by '08Mumbai-based Wockhardt Group plans to double the number of its hospitals from seven to 14 by 2008.
- Wockhardt plans to double hospitalsMumbai-based Wockhardt Group plans to double the number of its hospitals from seven to 14 by 2008. This will increase the cumulative bed ca...
- Wockhardt Hospitals to increase presence in BengalIn a move to consolidate presence in West Bengal, Wockhardt Hospitals Group is finalising plans to expand on its ‘hub and spoke’ model.
- Wockhardt to focus on emergency care with HMIWockhardt hospitals in association with Harvard Medical International (HMI) are undertaking a two-year certification programme for doctors ...
- Wockhardt tie-up with US coWockhardt Hospitals, a leading healthcare provider group, on Monday announced a strategic tie up with US based IndUShealth Inc., a global h...
Load More
